Insulet PODD Total Omnipod products — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's total omnipod products — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's total omnipod products — total revenue?
- Insulet (PODD) reported total omnipod products — total revenue of $758.4M in Q1 2026.
- How has Insulet's total omnipod products — total revenue changed year-over-year?
- Insulet's total omnipod products — total revenue increased by 36.9% year-over-year, from $554M to $758.4M.
- What is the long-term trend for Insulet's total omnipod products — total revenue?
- Over 4 years (2021 to 2025), Insulet's total omnipod products — total revenue has grown at a 27.5% compound annual growth rate (CAGR), from $1.01B to $2.67B.
- What does total omnipod products — total revenue mean?
- The total revenue generated from the sales of the company's core insulin delivery devices and associated consumables.
- How do you interpret total omnipod products — total revenue?
- An increase indicates strong market penetration, successful patient retention, or expanded adoption of the insulin delivery platform, while a decrease may signal competitive pressure or saturation in the diabetes technology market.
- How does total omnipod products — total revenue compare across companies?
- Comparable to revenue reported by other medical device manufacturers specializing in chronic disease management or wearable health technology.